Our R & D Center - Equipped with the most advanced technologies
Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617) founded in 2014 is a Taiwan based clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs.
Vaccines
90%
Medical Research
60%
ALAN OEAN, CO-FOUNDER
About us
Different types of
Products
PTS 100 Hepatic Cellular Carcinoma (HCC) (Trials ongoing in Taiwan)
PTS 02 Tracheal Adeno Cystic Carcinoma (ODD status with USFDA)
PTS 500 Malignant Pleural Effusion (Trials ongoing in Taiwan)
PTS 100 Hepatic Cellular Carcinoma (HCC) (Trials ongoing in Taiwan)
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.- Bone Slices
- Corticosterone EIA
- Dentine Discs
- Bone Slices
- Corticosterone EIA
- Dentine Discs
PTS 02 Tracheal Adeno Cystic Carcinoma (ODD status with USFDA)
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.- Bone Slices
- Bone Slices
PTS 500 Malignant Pleural Effusion (Trials ongoing in Taiwan)
WE ENSURE SAFE DIAGNOSES THERAPIES
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusan-tium doloremque laudantium.Lorem ipsum dolor sit amet,con sec tetur adipisicing elit,sed do.
- Bone Slices
- Corticosterone EIA
- Bone Slices
- Corticosterone EIA